Clinical Trial Update: A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor

View source ↗

Summary

This completed clinical trial compared adherence rates to Ritonavir and the protease inhibitor used alongside it in people with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir (Ritonavir)

Snippet

Sponsor: Montefiore Medical Center | Conditions: HIV Infections | Status: COMPLETED